GlobeNewswire by notified

TigerGraph’s Graph for All Million Dollar Challenge Winners Impress With Innovative Solutions to Global Issues Using Graph Technology


Top Projects Address Mental Health, Refugee Support, Detecting Organized Crime, Fighting Global Misinformation, and More

REDWOOD CITY, Calif., May 25, 2022 (GLOBE NEWSWIRE) -- TigerGraph, provider of a leading graph analytics platform, today unveiled the winners of the Graph for All Million Dollar Challenge — awarding $1 million in cash to game-changing, graph-powered projects that analyze and address many of today’s biggest global social, economic, health, and climate-related concerns. The winning projects, announced at this week’s Graph + AI Summit, were hand-selected by the global judging committee from more than 1,500 registrations from 100+ countries. Mental Health Hero claimed the $250k Grand Prize for creating an application to help provide greater access and personalization to mental health treatment.

“From addressing mental health issues to supporting Ukrainian refugees to predicting how supply shocks will spread through the world economy, the submissions we received tackle real-world concerns and demonstrate innovative approaches to resolving them with graph technology,” said Dr. Yu Xu, founder and CEO of TigerGraph. “We wanted to create a challenge that produced new and innovative applications of graph technology and the global community did just that. The overwhelming focus on global issues in this challenge shows that regardless of geography, we all share many of the same concerns and challenges, and that graph technology can help address them.”

Graph For All Million Dollar Challenge Winners
After extensive review by the global judging committee, consisting of 32 experts from industry, academia, and TigerGraph, the following are the 15 award-winning projects.

Graph For All Million Dollar Challenge Grand Prize Winner
Grand Prize, $250,000: Mental Health Hero - Mental Health Hero is a graph-based approach to solving one of the largest public health epidemics today: the prevalence of untreated mental health issues such as anxiety and depression. According to the CDC, 400 million people globally are not receiving essential treatment for their mental health disorders [1]. Additionally, only 40% of adults with mental illness are estimated to receive treatment for it [2].

Graph For All Million Dollar Challenge Top Awards
Most Impactful 1st place, $100,000: UAWelcome - The global refugee crisis reached a new level of awareness with the war in Ukraine. In response, UAWelcome created a platform that uses graph technology to connect individual refugees and their needs with a fast-growing community of volunteers and the limited and scattered resources. Their application is already in use connecting volunteers and scattered resources with Ukrainian refugees and helping refugees seek asylum in the U.S.

Most Innovative1st place, $100,000: Universe Planner - A multiverse-metaverse planning app that allows users to solve complex problems by tapping into and leveraging social knowledge. It also socially connects users to others working on the same or similar mission, plan, or task.

Most Ambitious 1st place, $100,000: ShockNet - Allows users to adjust assumptions, investigate the predicted chains of shocks through the world economy, and identify ways to avoid economic crises by gaining visibility into how and why shocks spread. ShockNet includes an app that allows policymakers to visualize and adjust the model to better understand how to offset or avoid a future crisis.

Most Applicable 1st place, $100,000: BioDex - BioDex combines our natural curiosity with the motivation of gaming. By gamifying the experience of connecting to nature, players can snap images of nature, identify its species, and display its properties in real time while striving to identify as many species as possible and contributing biodiversity information to research.

Women Who Graph, $30,000: Diagnosx - After seeing first hand in the ER the dual struggles of patients not understanding their health conditions and doctors trying to draw pictures to help explain conditions, Bree Day knew there had to be a better way. Her idea to get 3D models to illustrate breadth and depth of a patient's diagnosis into all patients’ hands is realized in Diagnosx. The application presents a 3D model of a patient's diagnosis and medical history to better illustrate the findings and diagnosis, and decrease disparities in doctor/patient communication.

Most Popular, $20,000:Multimodality Cancer Graph - Many diseases are related to each other, and complications from a certain disease could cause another. Through the power of graphs and machine learning, this project aims to uncover new disease links and help researchers better prepare for future pandemics or emerging diseases.

Additional Winners
Most Impactful

  • 2nd place, $50,000: Fact-Checker: Fighting Misinformation at Scale - A multi-platform, multi-lingual, real-time fact-checking system powered by machine learning and graph technology.
  • 3rd place, $25,000: Project Athena - An automatic, generic knowledge graph framework that builds itself from textual unstructured data and uses natural language to query and apply data.

Most Innovative

  • 2nd place, $50,000: RepoLinks - A graph that shows the dense, complex interconnections between software developers, programming languages, and software projects, to better understand factors such as skill sets, productivity, and technology evolution within organizations.
  • 3rd place, $25,000: Gemini - An eclectic news search engine that cuts through the noise and allows readers to dig deep into a specific topic or explore multiple facets of the news they are most interested in.

Most Ambitious

  • 2nd place, $50,000: Finding Drug Interactions in Silico with Graph - Identifies drug interactions and potential side effects using graph machine learning during the pharmaceutical development process.
  • 3rd place, $25,000: Candoor - A social networking site for people seeking to connect with others for candid conversations on anything from professional industry advice to tips for pursuing a hobby.

Most Applicable

  • 2nd place, $50,000: TigerGraph for United Nations (UN) Data - Makes UN data, the most robust dataset in the world, easily accessible to anyone by harnessing the power of graph technology.
  • 3rd place, $25,000: BiasCheck - A cool new Google Chrome extension that fosters critical thinking by identifying bias/accuracy of all news sources. The technology also allows users to explore specific topics with differing viewpoints that challenge the status quo.

The Graph for All Million Dollar Challenge judging committee was comprised of the world’s brightest and most recognizable data scientists, professors, PhDs, distinguished engineers, and founders of global companies focusing on artificial intelligence (AI), analytics, knowledge graph, and other industry experts with deep knowledge of graph technology, graph use cases, and graph deployments. The judging committee included eight PhDs, three academics from top universities, an NSF Graduate Research Fellow, a marine geoscientist, and a 2x Kaggle Grand Master. TigerGraph engineers and product experts also joined the panel as employee judges.

“Wow! The creative use of graph and data in these solutions really shows how a graph approach with the right data can address so many global issues,” said Juan Sequeda, principal scientist, and Graph for All Million Dollar Challenge judge. “What is truly exciting is that most of these projects can be expanded and applied in many different situations and use cases in the future. The projects serve as templates that can be adjusted, augmented, and adapted for other situations, helping make life better for even more people. Like the project created to help Ukrainian refugees, while it is excellent for refugee situations, that same application could be used to help people impacted by natural disasters throughout the world.”

Helpful Links

About TigerGraph
TigerGraph is a platform for advanced analytics and machine learning on connected data. Based on the industry’s first and only distributed native graph database, TigerGraph’s proven technology supports advanced analytics and machine learning applications such as fraud detection, anti-money laundering (AML), entity resolution, customer 360, recommendations, knowledge graph, cybersecurity, supply chain, IoT, and network analysis. The company is headquartered in Redwood City, California, USA. Start free with

Media Contacts:

North America
Tanya Carlsson
Offleash PR
+1 (707) 529-6139

Anne Harding
The Message Machine
+44 7887 682943

Rasheed Abu Bakar
+65 9112 6504

1 References

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 202224.6.2022 22:05:00 CEST | Press release

REPORT –ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June24, 2022 – ERYTECH Pharma (Nasdaq& Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcedthat its Annual General Meeting was held on Friday, June 24, 2022. At the meeting, all resolutions for which the Board of Directors recommended a vote in favor were adopted, including: Approval of the annual financial statements and consolidated financial statements for the year ended December 31, 2021;Allocation of the financial year's results;Approval of the statutory auditors’ special report on regulated agreements and commitments with related parties;Approval of the elements of total compensation and benefits paid or allocated for the year ended December 31, 2021, to Gil BEYEN, Chief Executive Officer and Jean-Paul KRESS, Chairman of the Board;Approval of the compens

Cleantech Building Materials: Results of Annual General Meeting24.6.2022 14:54:27 CEST | Press release

24 June 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER: CBM ISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC Results of Annual General Meeting The Annual General Meeting (“AGM”) of Cleantech Building Materials plc (“CBM” or the “Company”) was held in London earlier today, 24 June 2022. Details of the resolutions to be considered at the AGM were published in the Notice of AGM which was posted to Shareholders on 1 June 2022 and is available on the Company’s website: All resolutions as set out in the Notice of AGM were duly passed without discussion. In particular, the following resolutions were passed at the AGM. The AGM resolved to authorise the directors of the Company to allot shares and grant rights to subscribe for, or convert any security, into shares. The directors of the Company sought authority for the purposes of section 551 of the Companies Act to exercise all the powers of the Company to allot shares and grant ri

Novartis receives positive CHMP opinion for Scemblix®, a novel treatment for adult patients with chronic myeloid leukemia24.6.2022 13:13:19 CEST | Press release

With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at least two prior tyrosine kinase inhibitor treatments1 Positive opinion based on data from pivotal Phase III ASCEMBL trial, showing a near doubling in major molecular response rate for patients treated with Scemblix® (asciminib) vs. Bosulif®* (bosutinib) (25.5% vs. 13.2%) and more than three times lower discontinuation rate due to adverse reactions (5.8% vs 21.1%) at 24 weeks1 CHMP recommendation comes after the approval of Scemblix by the US FDA and other countries’ regulatory authorities, potentially broadening access for more patients to Novartis transformative therapies in CML Basel, June 24, 2022 — Novartis today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing au

Clariant’s shareholders approve all agenda items24.6.2022 11:30:00 CEST | Press release

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Integrated Report and Group Consolidated Financial Statements for fiscal year 2021 approvedGünter von Au reelected as Chairman of the Board of DirectorsThree new candidates join the Board of Directors: Ahmed Mohamed Alumar, Roberto César Gualdoni, Naveena ShastriConfirmed distribution of CHF 0.40 per shareKPMG confirmed as statutory auditor from 2022 MUTTENZ, JUNE 24, 2022 Clariant, a focused, sustainable, and innovative specialty chemical company, today held its 27th Annual General Meeting (AGM) where the shareholders approved all agenda items and resolutions as proposed by the Board of Directors. The AGM was held virtually, where shareholders were able to exercise their rights exclusively via the independent proxy. Overall, 698'945'298 shares or around 70.19 % of the share capital of Clariant were represented. Günter von Au was reelected as Chairman of the Board of Directors. Additionally, three new members were voted to join by a large majo

Cool Company Ltd. – Mandatory Notification Of Trade24.6.2022 11:01:19 CEST | Press release

EPS Ventures Ltd., close associate of Cyril Ducau, Chair of the Board of Cool Company Ltd. (the “Company”), has on 23 June 2022 acquired 7,865 shares in the Company at a price of NOK 90.274882 per share. Following the transaction, EPS Ventures Ltd. holds a total of 15,591,218 shares in the Company, equivalent to 38.97% of the Company’s shares. Please see the attached notification form in accordance with the Market Abuse Regulation article 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Primary insider notification form